Post-Op Radiation May Give Long-Term Protection Against Breast Cancer's Return
By Dennis Thompson HealthDay Reporter
FRIDAY, Aug. 9, 2024 -- Radiation therapy following surgery can keep breast cancer from returning for up to 10 years, a new study claims.
The study supports the current standard of care for early-stage breast cancer, which involves surgery followed by radiation therapy, researchers said.
“Our evidence suggests that radiotherapy protects against cancer returning in the same breast for up to 10 years,” said researcher Ian Kunkler, a professor of clinical oncology with the University of Edinburgh’s Institute of Genetics and Cancer.
“It supports the continued use of radiotherapy after breast-conserving surgery for most patients with early breast cancer,” Kunkler added in a university news release.
For the study, researchers analyzed results for 585 Scottish women who received treatment for early-stage breast cancer.
Half received radiation therapy, and half did not. Radiation therapy uses high doses of radiation to destroy any remaining cancer cells after a tumor has been removed from the breast.
After 10 years, 16% of those treated with radiation therapy had their cancer return in the same location, compared with 36% of those who didn’t receive radiation.
Overall average survival rates after 30 years were similar between the two groups – 19.2 years for those who got radiation therapy, and 18.7 for those who didn’t.
There were fewer deaths from breast cancer among those who got radiation therapy, 37% versus 46%.
However, there were more deaths from other cancers in the radiation therapy group, 20% versus 11%.
The study was published Aug. 7 in The Lancet Oncology journal.
“This 30-year study marks the longest follow-up of postoperative radiotherapy in the treatment of early-stage breast cancer,” said lead researcher Dr. Linda Williams, with the University of Edinburgh. “Long-term studies like this, which go beyond 10 years of follow-up, are crucial to fully assess the risks and benefits of treatments.”
Sources
- University of Edinburgh, news release, Aug. 7, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Cancer Prevention Not Yet Recovered From Pandemic-Era Declines, Report Says
THURSDAY, April 24, 2025 -- The effects of COVID-19 continue to reverberate in the cancer risk factors of Americans, a new American Cancer Society (ACS) study says. Screening for...
Most Women Are Comfortable With AI-Assisted Mammography
TUESDAY, April 22, 2025 -- Women are OK with having an AI program help doctors review mammograms performed for breast cancer screening, a new study says. About 7 out of 10 women...
Gene Test Predicts Urinary Problems From Prostate Cancer Radiation Therapy
WEDNESDAY, April 16, 2025 -- Radiation therapy is commonly used to treat prostate cancer, but it can cause embarrassing urinary problems in some men. But a new genetic test...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.